Bioinspired Coordination Micelles Integrating High Stability, Triggered Cargo Release, and Magnetic Resonance Imaging
Source abstract
Abstract
Catechol-Fe3+ coordinated micelles show the potential for achieving on-demand drug delivery and magnetic resonance imaging in a single nanoplatform. Herein, we developed bioinspired coordination-cross-linked amphiphilic polymeric micelles loaded with a model anticancer agent, doxorubicin (Dox). The nanoscale micelles could tolerate substantial dilution to a condition below the critical micelle concentration (9.4 ± 0.3 μg/mL) without sacrificing the nanocarrier integrity due to the catechol-Fe3+ coordinated core cross-linking. Under acidic conditions (pH 5.0), the release rate of Dox was significantly faster compared to that at pH 7.4 as a consequence of coordination collapse and particle de-cross-linking. The cell viability study in 4T1 cells showed no toxicity regarding placebo cross-linked micelles. The micelles with improved stability showed a dramatically increased Dox accumulation in tumors and hence the enhanced suppression of tumor growth in a 4T1 tumor-bearing mouse model. The presence of Fe3+ endowed the micelles T1-weighted MRI capability both in vitro and in vivo without the incorporation of traditional toxic paramagnetic contrast agents. The current work presented a simple “three birds with one stone” approach to engineer the robust theranostic nanomedicine platform.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Lanthanide and Transition Metal Complexes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Pharmaceutical Science & Technology, Tianjin Key Laboratory for Modern Drug Delivery & High Efficiency, and Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin University, Tianjin 300072, China
Funding
Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China · Tianjin Application Foundation and Advanced Technology · State Key Laboratory of Medicinal Chemical Biology, Nankai University
References (55)
Show source-provided references
1. 10.1021/nn900002m10.1021/nn900002m ↗
2. 10.1021/jacs.5b0997410.1021/jacs.5b09974 ↗
3. 10.1038/nmat234410.1038/nmat2344 ↗
4. 10.1016/j.nano.2012.05.01310.1016/j.nano.2012.05.013 ↗
5. 10.1038/nmat377610.1038/nmat3776 ↗
6. 10.1093/rb/rbw01210.1093/rb/rbw012 ↗
7. 10.1016/j.addr.2012.01.02010.1016/j.addr.2012.01.020 ↗
8. 10.1021/mp100253e10.1021/mp100253e ↗
9. 10.1021/ar200019c10.1021/ar200019c ↗
10. 10.1021/cr100025t10.1021/cr100025t ↗
11. 10.1039/c3tb20715c10.1039/c3tb20715c ↗
12. 10.1002/ejic.20150116610.1002/ejic.201501166 ↗
13. 10.1021/acsnano.5b0356910.1021/acsnano.5b03569 ↗
14. 10.1016/j.biomaterials.2012.09.03010.1016/j.biomaterials.2012.09.030 ↗
15. 10.7150/thno.1468910.7150/thno.14689 ↗
16. 10.1126/science.114724110.1126/science.1147241 ↗
17. 10.1073/pnas.101586210810.1073/pnas.1015862108 ↗
18. 10.1039/c4cc01584c10.1039/c4cc01584c ↗
19. 10.1021/cr400407a10.1021/cr400407a ↗
20. 10.1002/smll.20150275410.1002/smll.201502754 ↗
21. 10.1021/ar200094a10.1021/ar200094a ↗
22. 10.1016/S0169-409X(02)00226-010.1016/S0169-409X(02)00226-0 ↗
23. 10.1016/j.jconrel.2011.12.02110.1016/j.jconrel.2011.12.021 ↗
24. 10.1016/j.jconrel.2011.09.09810.1016/j.jconrel.2011.09.098 ↗
25. 10.1007/s11095-012-0848-810.1007/s11095-012-0848-8 ↗
26. 10.1021/jm060094910.1021/jm0600949 ↗
27. 10.1016/j.jconrel.2004.06.00310.1016/j.jconrel.2004.06.003 ↗
28. 10.1016/S0168-3659(00)00280-710.1016/S0168-3659(00)00280-7 ↗
29. 10.1016/j.ejpb.2014.11.00210.1016/j.ejpb.2014.11.002 ↗
30. 10.1007/s11095-006-9132-010.1007/s11095-006-9132-0 ↗
31. 10.1016/j.nantod.2012.01.00210.1016/j.nantod.2012.01.002 ↗
32. 10.1021/mz300522n10.1021/mz300522n ↗
33. 10.1016/j.nantod.2015.01.00510.1016/j.nantod.2015.01.005 ↗
34. 10.1517/1742524090338044610.1517/17425240903380446 ↗
35. 10.1111/j.2042-7158.2012.01523.x10.1111/j.2042-7158.2012.01523.x ↗
36. 10.1021/ja203077x10.1021/ja203077x ↗
37. 10.1021/acsnano.5b0318410.1021/acsnano.5b03184 ↗
38. 10.1016/S0168-3659(99)00248-510.1016/S0168-3659(99)00248-5 ↗
39. 10.1016/j.addr.2013.11.00910.1016/j.addr.2013.11.009 ↗
40. 10.1016/j.jconrel.2011.06.00110.1016/j.jconrel.2011.06.001 ↗
41. Moghimi S. M. · Pharmacol. Rev. · 2001 · 53 · 28310.1016/S0031-6997(24)01494-7 ↗
42. 10.1038/nmat378010.1038/nmat3780 ↗
43. 10.1038/nbt.333010.1038/nbt.3330 ↗
44. 10.1021/nn500498t10.1021/nn500498t ↗
45. 10.1021/acs.molpharmaceut.5b0063110.1021/acs.molpharmaceut.5b00631 ↗
46. 10.1021/nn401079610.1021/nn4010796 ↗
47. 10.1056/NEJM19910321324121010.1056/NEJM199103213241210 ↗
48. 10.1056/NEJM19991223341260710.1056/NEJM199912233412607 ↗
49. 10.1126/science.110474210.1126/science.1104742 ↗
50. 10.1016/S0891-5849(02)01006-710.1016/S0891-5849(02)01006-7 ↗
51. Munro H. N. · Physiol. Rev. · 1978 · 58 · 31710.1152/physrev.1978.58.2.317 ↗
52. 10.1088/0957-4484/26/11/11510110.1088/0957-4484/26/11/115101 ↗
53. 10.1021/nn401079610.1021/nn4010796 ↗
54. 10.1016/j.biomaterials.2014.01.01810.1016/j.biomaterials.2014.01.018 ↗
55. 10.1016/j.actbio.2014.12.00110.1016/j.actbio.2014.12.001 ↗